Application Note

Expansion Of Specific Lymphocytes With 4Cell® Nutri-T Xeno-Free And Serum-Free Medium

Source: Sartorius

By Michal J. Besser, Katya Israel, Dragoslav Zikich, Sharon Daniliuc, Mira Genser Nir, Marina Teverovski, Adi Aizenshtat, Julia Hupfeld, Kyle Ritchie, Kat Kozyrytska, Anna Quach, Alexander Tappe, David Fiorentini, and Maya Fuerstenau-Sharp

T Cell attacking cancer cell GettyImages-862601694

Autologous CAR-T therapy success hinges on the robust expansion of specific subpopulations of patient-derived immune cells. Successful expansion is reliant on the use of media tailored for this specific purpose, ideally devoid of serum as it introduces variability that can lead to a lack of reproducibility and increased patient risk. This application note elucidates the advantages of a xeno- and serum-free medium for the targeted expansion of cell subpopulations without the addition of serum. This medium enables robust manufacturing processes, facilitates process control, and demonstrates exceptional performance in terms of fold expansion.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online